The unique nature of the Tecrea nanotechnology means Nanocin products are effectively non-toxic, typically maintaining at least 99% cell viability during transfection. Producing higher yields and more reliable results in scalable AAV and Lentivirus production, Nanocin allows you to take your research from lab to clinic with absolute confidence.
Bioprocessing engineering has emerged in recent years as an integral part of biotechnology. Its wide scale application produces a range of high-value products in the fields of gene therapy, monoclonal antibodies, recombinant proteins, amino acids, and vaccines.
Despite providing an increasingly invaluable source of biologics, one of the biggest challenges facing the bioprocessing community is carrying out GMP-compliant, large-scale transfection in bioreactors. Nanocin GMP offers a potential solution to some of these challenges.
Even small traces of toxicity within the transfection process can compromise results and reduce yields.
Tecrea is redefining efficiency in the field of molecular medicine research and development with Nanocin transfection reagents, producing unmatched levels of accuracy, speed and delivery.
Nanocin cell delivery technology has been engineered to be effectively non-toxic, creating higher levels of cell viability, often greater than 99%, which results in higher yields.
Alongside being effectively non-toxic, Nanocin products employ simple protocols for highly efficient, fast transfection.
Because they don’t compromise cell viability, Nanocin products also support serial transfections, and their positive safety profile means they can be used with even the most sensitive cells.
Secure higher yields with more reliable results in scalable AAV and Lentivirus production with Nanocin cell delivery technology.